C[O:2][C:3]([C:5]1[CH:10]=[C:9]([CH2:11][C:12]2[CH:17]=[CH:16][C:15]([F:18])=[CH:14][CH:13]=2)[C:8]([Cl:19])=[CH:7][N:6]=1)=[O:4].[OH-].[Na+].Cl.C(OCC)(=O)C>C1COCC1>[Cl:19][C:8]1[C:9]([CH2:11][C:12]2[CH:17]=[CH:16][C:15]([F:18])=[CH:14][CH:13]=2)=[CH:10][C:5]([C:3]([OH:4])=[O:2])=[N:6][CH:7]=1To a solution of 5-chloro-4-(4-fluorobenzyl)-pyridine-2-carboxylic acid methyl ester (190 mg, 0.68 mmol) in THF (10 mL) was added sodium hydroxide solution (1.36 mL, 1 N). The resulting solution was stirred at room temperature for 2 hours, and afterwards acidified with hydrochloric acid (15 mL, 1N) and poured into ethyl acetate (50 mL). The phases were separated and the water phase was extracted with additional ethyl acetate; the organic portions were combined, dried over Na2SO4, filtered and concentrated. The crude material (186 mg, quant.) a white solid, was sufficiently pure to be used in the next step without further purification. MS (ESI, m/z): 264.0 (M−H−).